Benzinga | Aug 10, 2021 04:50PM EDT

Day One Biopharmaceutical Q2 EPS $(5.04) Down From $(0.32) YoY

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(5.04) per share. This is a 1475 percent decrease over losses of $(0.32) per share from the same period last year.